Conferences

Reports from professional meetings related to nonmelanoma skin cancers.
Should We Treat the Regional Nodes in Patients with Skin Cancer of the Head and Neck with Perineural Invasion
Presenter: A. Garcia-SerraPresenter's Affiliation: Department of Radiation Oncology, University of Florida, Gainesville, FL, USAType of Session: ScientificBackground Once the decision to treat a patient with radiation therapy has been made, ..
Early Study Results Promising: Oral Medication Active Against Skin Cancer
Abramson Cancer Center Research Presented at ASCO: Abstract #2854 FOR IMMEDIATE RELEASE (Saturday, May 31, 2003, Chicago, IL) - Researchers from the Abramson Cancer Center of the University of Pennsylvania ..
Neoadjuvant Chemotherapy Followed by Preoperative Radiochemotherapy (hfRTCT) Plus Surgery or Surgery Plus Postoperative Radiotherapy in Stage III Non-Small Cell Lung Cancer: Results of a Randomized Phase III Trial of the German Lung Cancer Cooperative Group
Presenter: C. BuchePresenter's Affiliation: German Lung Cancer Cooperative GroupType of Session: PlenaryBackground The optimal treatment for patients with stage III non-small cell lung cancer (NSCLC) is controversial. Ideally, patients with ..
S9900: A phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC): Preliminary results
Presenter: K. PistersPresenter's Affiliation: MD Anderson Cancer CenterType of Session: ScientificBackground Five year Overall Survival (OS) for stages T2NO-T3N1 NSCLC are low, ranging from 9-38%. When this study was designed ..
Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer
Presenter: V. Westeel, MD, on behalf of the Intergroupe Francophone de Cancerologie Thoracique Background This is an update of a previously reported French Phase III randomized trial (DePierre, JCO 2002) ..
Chemoradiation With or Without Surgery for Stage IIIA Non-Small Cell Lung Cancer (NSCLC): A Comparison of Survival and Patterns of Failure
Presenter: Mitchell Machtay, MD Affiliation: University of Pennsylvania Background:One of the most controversial topics in the management of NSCLC is the treatment of stage IIIA disease. Chemotherapy is generally accepted ..
Concurrent Chemo-Radiation Results in Equivalent Local and Overall Outcome as Induction Chemotherapy Followed by Surgery for Clinical Stage IIIA Non-Small Cell Lung Cancer
Presenter: N.A. TaylorPresenter's Affiliation: Department of Radiation Oncology, UT M.D. Anderson Cancer Center, Houston, TX, USAType of Session: ScientificBackground In this study, investigators looked at 2 different treatment regimens for ..
A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941)
Presenter: J. van MeerbeeckPresenter's Affiliation: University Hospital, Ghent, BelgiumType of Session: PlenaryBackground There remains significant controversy in the optimal treatment of patients with locally advanced stage IIIA NSCLC with ipsilateral ..

News
Topical methyl aminolevulinate and Wood lamp examination effectively delineate margins pre-MMS

Apr 27, 2011 - Use of topical methyl aminolevulinate as a photosensitizer in conjunction with Wood lamp examination is a feasible method for identifying tumor margins in patients with basal cell carcinoma prior to Mohs micrographic surgery, according to a study published in the May issue of the Journal of the American Academy of Dermatology.



I Wish You Knew

What is Photodynamic Therapy and how is it used in cancer care?

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More